BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22297547)

  • 1. Serum biomarker profiles as diagnostic tools in lung cancer.
    Nolen BM; Langmead CJ; Choi S; Lomakin A; Marrangoni A; Bigbee WL; Weissfeld JL; Wilson DO; Dacic S; Siegfried JM; Lokshin AE
    Cancer Biomark; 2011-2012; 10(1):3-12. PubMed ID: 22297547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.
    Bigbee WL; Gopalakrishnan V; Weissfeld JL; Wilson DO; Dacic S; Lokshin AE; Siegfried JM
    J Thorac Oncol; 2012 Apr; 7(4):698-708. PubMed ID: 22425918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
    Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum biomarker panels for the detection of pancreatic cancer.
    Brand RE; Nolen BM; Zeh HJ; Allen PJ; Eloubeidi MA; Goldberg M; Elton E; Arnoletti JP; Christein JD; Vickers SM; Langmead CJ; Landsittel DP; Whitcomb DC; Grizzle WE; Lokshin AE
    Clin Cancer Res; 2011 Feb; 17(4):805-16. PubMed ID: 21325298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.
    Du Q; Li E; Liu Y; Xie W; Huang C; Song J; Zhang W; Zheng Y; Wang H; Wang Q
    Cancer Med; 2018 Feb; 7(2):325-335. PubMed ID: 29356357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium.
    Pils D; Tong D; Hager G; Obermayr E; Aust S; Heinze G; Kohl M; Schuster E; Wolf A; Sehouli J; Braicu I; Vergote I; Van Gorp T; Mahner S; Concin N; Speiser P; Zeillinger R
    BMC Cancer; 2013 Apr; 13():178. PubMed ID: 23551967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer.
    Kubasiak JC; Seder CW; Pithadia R; Basu S; Fhied C; Phillips WW; Daly S; Shersher DD; Yoder MA; Chmielewski G; Edell ES; Maldonado F; Liptay MJ; Borgia JA
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):727-34.e1-3; discussion 734. PubMed ID: 25312225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
    Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
    Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.
    Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A
    J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer.
    Blanco-Prieto S; Vázquez-Iglesias L; Rodríguez-Girondo M; Barcia-Castro L; Fernández-Villar A; Botana-Rial MI; Rodríguez-Berrocal FJ; de la Cadena MP
    PLoS One; 2015; 10(5):e0127318. PubMed ID: 25992884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.
    Borgia JA; Basu S; Faber LP; Kim AW; Coon JS; Kaiser-Walters KA; Fhied C; Thomas S; Rouhi O; Warren WH; Bonomi P; Liptay MJ
    J Thorac Oncol; 2009 Mar; 4(3):338-47. PubMed ID: 19190517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
    Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T
    BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer.
    Jiang YM; Yu DL; Hou GX; Jiang JL; Zhou Q; Xu XF
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31296790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-analyte serum test for the detection of non-small cell lung cancer.
    Farlow EC; Vercillo MS; Coon JS; Basu S; Kim AW; Faber LP; Warren WH; Bonomi P; Liptay MJ; Borgia JA
    Br J Cancer; 2010 Oct; 103(8):1221-8. PubMed ID: 20859284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.